CANCERVAX Trademark

Trademark Overview

On Thursday, June 3, 2021, a trademark application was filed for CANCERVAX with the United States Patent and Trademark Office. The USPTO has given the CANCERVAX trademark a serial number of 90752328. The federal status of this trademark filing is REGISTERED as of Tuesday, April 2, 2024. This trademark is owned by CancerVAX, Inc.. The CANCERVAX trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Research and development of vaccines and medications for cancer
cancervax

General Information

Serial Number90752328
Word MarkCANCERVAX
Filing DateThursday, June 3, 2021
Status700 - REGISTERED
Status DateTuesday, April 2, 2024
Registration Number7349013
Registration DateTuesday, April 2, 2024
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Pseudo MarkCANCER VAX
Goods and ServicesResearch and development of vaccines and medications for cancer

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, August 26, 2021
Primary Code042
First Use Anywhere DateWednesday, May 26, 2021
First Use In Commerce DateWednesday, May 26, 2021

Trademark Owner History

Party NameCancerVAX, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressSanta Barbara, CA 93101
Party NameCancerVAX, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSanta Barbara, CA 93101

Trademark Events

Event DateEvent Description
Tuesday, April 2, 2024NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, April 2, 2024REGISTERED-SUPPLEMENTAL REGISTER
Thursday, February 22, 2024EXPARTE APPEAL TERMINATED
Thursday, February 22, 2024APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER
Monday, August 21, 2023JURISDICTION RESTORED TO EXAMINING ATTORNEY
Friday, June 16, 2023NOTIFICATION OF ACTION DENYING REQ FOR RECON E-MAILED
Friday, June 16, 2023ACTION DENYING REQ FOR RECON E-MAILED
Friday, June 16, 2023ACTION CONTINUING FINAL - COMPLETED
Monday, March 27, 2023TEAS REQUEST FOR RECONSIDERATION RECEIVED
Monday, March 27, 2023EX PARTE APPEAL-INSTITUTED
Monday, March 27, 2023JURISDICTION RESTORED TO EXAMINING ATTORNEY
Monday, March 27, 2023EXPARTE APPEAL RECEIVED AT TTAB
Tuesday, March 7, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, March 7, 2023TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Tuesday, March 7, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, March 7, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, September 27, 2022NOTIFICATION OF FINAL REFUSAL EMAILED
Tuesday, September 27, 2022FINAL REFUSAL E-MAILED
Tuesday, September 27, 2022FINAL REFUSAL WRITTEN
Friday, August 19, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, August 18, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, August 18, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, February 18, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, February 18, 2022NON-FINAL ACTION E-MAILED
Friday, February 18, 2022NON-FINAL ACTION WRITTEN
Thursday, February 17, 2022ASSIGNED TO EXAMINER
Thursday, August 26, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, June 7, 2021NEW APPLICATION ENTERED

Related Keywords

cancervax cancer medications vaccines development research